The authors examine the risks of extractables and leachables and present solutions that emphasize the importance of a strategic multi-prong approach.
Alan Xu
Advertisement
Alan Xu is product manager, analytical services at Stevanato Group
Articles by Alan Xu
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
3
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
4
Beam's Risto-cel Meets Primary Endpoint in Sickle Cell Trial
5